Zobrazeno 1 - 10
of 64
pro vyhledávání: '"H, Vanquaethem"'
Autor:
C. Helissey, C. Parnot, C. Rivière, C. Duverger, A. Schernberg, S. Becherirat, H. Picchi, A. Le Roy, P. Vuagnat, R. Pristavu, H. Vanquaethem, L. Brureau
Publikováno v:
Frontiers in Digital Health, Vol 5 (2023)
Research aim and purposeThe benefits of Electronic Patient -Reported Outcomes (e-PRO) for telemonitoring are well established, allowing early detection of illnesses and continuous monitoring of patients. The primary objective of the PROTECTY study wa
Externí odkaz:
https://doaj.org/article/11990258219a4d839de2c10ec42073d2
Autor:
A. Ciavaldini, C. Delattre, A. Bousquet, R. Mestiri, A.-T. Nguyen, H. Vanquaethem, P.-L. Conan, W. Caré
Publikováno v:
La Revue de Médecine Interne. 44:195-198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43d3ae6a9752143e45f5594dcbc753aa
https://doi.org/10.1016/j.revmed.2022.12.006
https://doi.org/10.1016/j.revmed.2022.12.006
Autor:
T. Chaara, L. Gilardin, H. Nielly, S. Le Burel, A. Bousquet, C. Beaucreux, K. Kearns, A. Salvadori, M. Piljan, M. Sollier, J. Mayaux, B. Rohaut, L. Le Guennec, H. Vanquaethem, A. Michon
Publikováno v:
La Revue de Médecine Interne. 43:328-331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::092149992f3d5391e32185a8c81ed415
https://doi.org/10.1016/j.revmed.2022.04.015
https://doi.org/10.1016/j.revmed.2022.04.015
Autor:
M. Lhaiba, W. Caré, H. Vanquaethem, R. Mestiri, G. Cassouret, T. Chaara, S. Le Burel, H. Nielly
Publikováno v:
La Revue de Médecine Interne. 43:A229-A230
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e80ecb4eefe97c14a53ee6640c8060f0
https://doi.org/10.1016/j.revmed.2022.03.185
https://doi.org/10.1016/j.revmed.2022.03.185
Autor:
H. Bréchet, W. Caré, H. Vanquaethem, R. Mestiri, C. Ranc, T. Chaara, J. Paez, S. Le Burel, L. Gilardin, L. Thomas, A. Courtiol, A. Woloch, H. Nielly
Publikováno v:
La Revue de Médecine Interne. 43:A211-A212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03811eed435689b5f419f0685b293ee0
https://doi.org/10.1016/j.revmed.2022.03.155
https://doi.org/10.1016/j.revmed.2022.03.155
Autor:
M. Peron, M. Zinger, Anna Schmitt, F. Maloisel, Stéphane Bouchard, K. Dû, F. Denis, M.‐P. Moles, H. Bourgeois, M. Goff, H. Vanquaethem, A.-L. Septans
Publikováno v:
Hematological Oncology. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ee3862d9781a19f75881a8119cf94dd
https://doi.org/10.1002/hon.102_2881
https://doi.org/10.1002/hon.102_2881
Publikováno v:
Annals of Oncology. 32:S1187-S1188
Background: More than 50% of new cancers are diagnosed in EP over the age of 70. The COVID-19 pandemic was particularly challenging for EP, which are the most fragile against both diseases. Telemedicine has clearly developed during this period but it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0356a1879ca7592edb15945c609f748d
https://doi.org/10.1016/j.annonc.2021.08.1675
https://doi.org/10.1016/j.annonc.2021.08.1675
Autor:
J.L. Charuel, L. Mouthon, H. Nunes, B. Dunogué, H. Vanquaethem, Paul Breillat, K. Mariampillai, Yurdagul Uzunhan, F. Ackermann, Makoto Miyara, Paul Legendre, O. Benveniste, P. Martins, Y. Allenbach
Publikováno v:
La Revue de Médecine Interne. 42:A91-A92
Resume Introduction Les auto-anticorps aident le clinicien a classer les maladies auto-immunes systemiques en sous-groupes homogenes selon le phenotype clinique et le pronostic associe. Les anticorps anti-PM-Scl, tres rarement observes, ont ete decri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c60bc867eae9d2d795a65b58b5f238f
https://doi.org/10.1016/j.revmed.2021.03.316
https://doi.org/10.1016/j.revmed.2021.03.316
Autor:
Laurent Gilardin, A. Olry, J.D. Burdairon, H. Nielly, H. Vanquaethem, T. Chaara, C. Dubost, X. Phina-Ziebin, S. Le Burel
Publikováno v:
La Revue de Médecine Interne. 42:A75-A76
Introduction Le Levetiracetam (LEV) est indique chez le patient epileptique dans le traitement des crises partielles avec ou sans generalisation secondaire chez l’adulte. Le LEV, comme tous les medicaments antiepileptiques (MAE), est pourvoyeur d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::551715d1b2874bc3bf018abb6af1c3a0
https://doi.org/10.1016/j.revmed.2021.03.291
https://doi.org/10.1016/j.revmed.2021.03.291
Autor:
P. Breillat, K. Mariampillai, P. Martins, P. Legendre, J.L. Charuel, M. Miyara, B. Dunogue, H. Vanquaethem, F. Ackermann, O. Benveniste, H. Nunes, L. Mouthon, Y. Allenbach, Y. Uzunhan
Publikováno v:
Revue des Maladies Respiratoires Actualités. 14:48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5958681351943b570ba7b1301442c33d
https://doi.org/10.1016/j.rmra.2021.11.528
https://doi.org/10.1016/j.rmra.2021.11.528